Search Results - Staab, T.R

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Dilemma of Cross-Over Trials and Their Impact on Benefit Assessment In Oncology

    Dilemma of Cross-Over Trials and Their Impact on Benefit Assessment In Oncology by Ruof, J, Staab, T.R, Walter, M

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The Risky Business of Drug Development: The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Arduous Development Journey – As Illustrated By The Decisions Of Germany's Gemeinsamer Bundesausschuss (G-Ba)

    The Risky Business of Drug Development: The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Arduous Devel... by Maetzel, A, Staab, T.R, Ruof, J

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Comparison of Post-Authorisation Measures From Regulatory Authorities With Additional Evidence Requirements From HTA Bodies in Germany

    Comparison of Post-Authorisation Measures From Regulatory Authorities With Additional Evidence Requirements From HTA Bodies in Germany by Ruof, J, Staab, T.R, Slawik, L, Orben, T, Bosch, S

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    PHP210 - The Risky Business of Drug Development: The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Arduous Development Journey – As Illustrated By The Decisions Of Germany's Gemeinsamer Bundesausschuss (G-Ba)

    PHP210 - The Risky Business of Drug Development: The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Ardu... by Maetzel, A., Staab, T.R., Ruof, J.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    PCN248 - Dilemma of Cross-Over Trials and Their Impact on Benefit Assessment In Oncology

    PCN248 - Dilemma of Cross-Over Trials and Their Impact on Benefit Assessment In Oncology by Ruof, J., Staab, T.R., Walter, M.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    PHP139 - Comparison of Post-Authorisation Measures From Regulatory Authorities With Additional Evidence Requirements From HTA Bodies in Germany

    PHP139 - Comparison of Post-Authorisation Measures From Regulatory Authorities With Additional Evidence Requirements From HTA Bodies in Germany by Ruof, J., Staab, T.R., Slawik, L., Orben, T., Bosch, S.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: